Pathology Research Services Core Shared Resource ABSTRACT Pathology studies at City of Hope Comprehensive Cancer Center (COHCCC) are supported by the Pathology Research Services Core (PRSC), which is composed of three distinct laboratories (Research Histology, Molecular Pathology, and Cytogenetics) and the COHCCC institutional biorepository. The overall goal of the PRSC is to provide COHCCC investigators with access to high quality, timely, and cost-effective pathology services that directly support both animal and human studies, and to provide access to ethically consented and procured human biorepository collections. The biorepository services include patient consenting to COH?s General Research Protocol, thus allowing the PRSC to procure residual solid tissue, additional bone marrow aspirate, and peripheral blood, as well as buccal cells and skin biopsies. With consent in place, biospecimens are ethically procured under the supervision of pathologists, processed, stored, and fully annotated following ISBER Best Practices and NCI Best Practices for Biospecimen Resources. The PRSC is preparing for College of American Pathologists (CAP) Biorepository Accreditation in late 2018. The PRSC also provides expert histopathology (solid and liquid tumors) and molecular and cytogenetics support for translational research by COHCCC investigators. The PRSC, including the institutional biorepository, is overseen by an Internal Advisory Board; the Director, Dennis Weisenburger, MD; and an operations Senior Manager, Karen Miller CLS, MT(ASCP). Oversight is provided by an interdisciplinary faculty Advisory Committee, and user feedback is obtained through an annual survey. The leaders of the laboratories sit on the Advisory Committee and are available for project design and technical consultation as needed. Since the last competing renewal, the PRSC, including the biorepository, was used by 183 unique investigators, 63% (n=116) of whom were CC members and representing all five Programs. The PRSC distributed 794 fresh frozen tissue aliquots, 674 aliquots of serum/plasma/buffy coats, 738 vials of mononuclear cells/peripheral blood mononuclear cells (MNC/PBMCs) (2015-2016 data), and 45,675 formalin-fixed paraffin-embedded (FFPE) sections from clinical and research tissue blocks. The biorepository frozen tissue collection has grown to 20,500 solid tissues (tumor and paired normal tissue when available); 28,360 vials of MNC/PBMCs from bone marrow, peripheral blood, or apheresis products; 50,665 aliquots of serum; 41,620 aliquots of plasma; and 21,500 buffy coats from peripheral blood. The research- only FFPE tissue collection comprises approximately 12,000 blocks.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Beckman Research Institute/City of Hope
United States
Zip Code
Slavin, Thomas P; Banks, Kimberly C; Chudova, Darya et al. (2018) Identification of Incidental Germline Mutations in Patients With Advanced Solid Tumors Who Underwent Cell-Free Circulating Tumor DNA Sequencing. J Clin Oncol :JCO1800328
Yun, Xinwei; Zhang, Keqiang; Wang, Jinhui et al. (2018) Targeting USP22 Suppresses Tumorigenicity and Enhances Cisplatin Sensitivity Through ALDH1A3 Downregulation in Cancer-Initiating Cells from Lung Adenocarcinoma. Mol Cancer Res 16:1161-1171
Herrera, Alex F; Rodig, Scott J; Song, Joo Y et al. (2018) Outcomes after Allogeneic Stem Cell Transplantation in Patients with Double-Hit and Double-Expressor Lymphoma. Biol Blood Marrow Transplant 24:514-520
Oh, Eunjin; Ahn, Miwon; Afelik, Solomon et al. (2018) Syntaxin 4 Expression in Pancreatic ?-Cells Promotes Islet Function and Protects Functional ?-Cell Mass. Diabetes 67:2626-2639
Shahin, Sophia A; Wang, Ruining; Simargi, Shirleen I et al. (2018) Hyaluronic acid conjugated nanoparticle delivery of siRNA against TWIST reduces tumor burden and enhances sensitivity to cisplatin in ovarian cancer. Nanomedicine 14:1381-1394
Wittenberg, Elaine; Ferrell, Betty; Koczywas, Marianna et al. (2018) Pilot Study of a Communication Coaching Telephone Intervention for Lung Cancer Caregivers. Cancer Nurs 41:506-512
Zhang, Keqiang; Wang, Jinhui; Yang, Lu et al. (2018) Targeting histone methyltransferase G9a inhibits growth and Wnt signaling pathway by epigenetically regulating HP1? and APC2 gene expression in non-small cell lung cancer. Mol Cancer 17:153
Zhang, Bin; Nguyen, Le Xuan Truong; Li, Ling et al. (2018) Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemia. Nat Med 24:450-462
Kirschbaum, Mark H; Frankel, Paul; Synold, Timothy W et al. (2018) A phase II study of vascular endothelial growth factor trap (Aflibercept, NSC 724770) in patients with myelodysplastic syndrome: a California Cancer Consortium Study. Br J Haematol 180:445-448
Liu, Liang; Yang, Lin; Yan, Wei et al. (2018) Chemotherapy Induces Breast Cancer Stemness in Association with Dysregulated Monocytosis. Clin Cancer Res 24:2370-2382

Showing the most recent 10 out of 1396 publications